We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-5.97%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.6B
AUM Growth
-$228M
(-1.6%)
Cap. Flow
+$864M
Cap. Flow
% of AUM
6.34%
Top 10 Holdings %
Top 10 Hldgs %
11.84%
Holding
3,164
New
256
Increased
959
Reduced
778
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$70.9M |
| 2 |
Omnicom Group
OMC
|
+$59.3M |
| 3 |
IPG
Interpublic Group of Companies
IPG
|
+$44M |
| 4 |
Avery Dennison
AVY
|
+$38.3M |
| 5 |
FNB Corp
FNB
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Macy's
M
|
+$55.7M |
| 2 |
Corning
GLW
|
+$49.4M |
| 3 |
Southwest Airlines
LUV
|
+$36.6M |
| 4 |
Texas Instruments
TXN
|
+$34.1M |
| 5 |
eBay
EBAY
|
+$34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.4% |
| 2 | Healthcare | 14.04% |
| 3 | Financials | 12.22% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Discretionary | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
BWX Technologies
BWXT
$16.2B
| $382K | ﹤0.01% |
14,545
-5,873
| -29% | -$150K |
|
|
MNTA
902
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $382K | ﹤0.01% |
+23,284
| New | +$477K |
|
903
InterDigital
IDCC
$6.7B
| $381K | ﹤0.01% |
7,547
| – | – |
|
904
Gentherm
THRM
$1.29B
| $377K | ﹤0.01% |
8,410
+28
| +0.3% | +$1.34K |
|
905
Douglas Dynamics
PLOW
$1.04B
| $376K | ﹤0.01% |
18,993
+162
| +0.9% | +$3.44K |
|
906
Usana Health Sciences
USNA
$412M
| $376K | ﹤0.01% |
5,616
+1,070
| +24% | +$75.7K |
|
907
Encompass Health
EHC
$11.3B
| $375K | ﹤0.01% |
+12,301
| New | +$428K |
|
|
HNT
908
DELISTED
HEALTH NET INC
HNT
| $375K | ﹤0.01% |
6,251
-21,383
| -77% | -$1.42M |
|
909
Ford
F
$58.5B
| $374K | ﹤0.01% |
27,663
-711
| -3% | -$10.2K |
|
910
MKS Inc
MKSI
$21.3B
| $374K | ﹤0.01% |
11,164
| – | – |
|
|
UNIT
911
Uniti Group
UNIT
$2.62B
| $373K | ﹤0.01% |
20,874
+892
| +4% | +$19.1K |
|
|
CVC
912
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $372K | ﹤0.01% |
11,477
-28
| -0.2% | -$762 |
|
913
BCE
BCE
$19.8B
| $369K | ﹤0.01% |
9,034
-1,010
| -10% | -$41.5K |
|
914
Progress Software
PRGS
$1.59B
| $369K | ﹤0.01% |
14,304
| – | – |
|
|
DNB
915
DELISTED
Dun & Bradstreet
DNB
| $369K | ﹤0.01% |
3,527
-299
| -8% | -$34.1K |
|
916
Community Health Systems
CYH
$383M
| $367K | ﹤0.01% |
10,435
-816
| -7% | -$37.4K |
|
|
SGMO
917
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $366K | ﹤0.01% |
64,986
+36,000
| +124% | +$297K |
|
918
Shake Shack
SHAK
$2.48B
| $365K | ﹤0.01% |
7,725
+1,000
| +15% | +$54.5K |
|
|
SRDX
919
DELISTED
Surmodics
SRDX
| $365K | ﹤0.01% |
16,772
+180
| +1% | +$4.22K |
|
920
VanEck Environmental Services ETF
EVX
$100M
| $364K | ﹤0.01% |
31,465
| – | – |
|
921
Roper Technologies
ROP
$37.1B
| $364K | ﹤0.01% |
2,332
-130
| -5% | -$21.5K |
|
|
HR
922
DELISTED
Healthcare Realty Trust Incorporated
HR
| $364K | ﹤0.01% |
14,755
-5,830
| -28% | -$139K |
|
923
FirstEnergy
FE
$28.5B
| $363K | ﹤0.01% |
11,621
| – | – |
|
924
Goodyear
GT
$2.04B
| $362K | ﹤0.01% |
12,343
| – | – |
|
|
BGC
925
DELISTED
General Cable Corporation
BGC
| $360K | ﹤0.01% |
30,381
+30,232
| +20,290% | +$471K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2015 Portfolio in Review
As of Q3 2015, Glenmede Trust held 3,164 positions worth $13.6B, down 1.6% from $13.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $864M of net new capital in Q3 2015, opening 256 new positions and adding to 959 existing holdings. Its largest new stake was PayPal: 1,978,444 shares worth $61.4M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Macy's, an estimated $55.7M trimmed.
- Glenmede Trust's largest Q3 2015 buy was PayPal: 1,978,444 shares worth $61.4M.
- Glenmede Trust added most to Omnicom Group in Q3 2015, an estimated $59.3M increase.
- Glenmede Trust's biggest Q3 2015 reduction was Macy's, cutting an estimated $55.7M.
- Glenmede Trust fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015, selling an estimated $18.8M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.6B portfolio in Q3 2015.
- Glenmede Trust opened 256 new positions and closed 260 in Q3 2015.
- Glenmede Trust's portfolio value fell 1.6% quarter-over-quarter to $13.6B.
Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.